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Abstract Inverted papillomas may affect the (para)nasal
cavity. While some of these papillomas can undergo
malignant transformation, others grow slowly and cause
few if any symptoms. An endoscopic approach is seen as
providing a balance between the greatest removal possible
and avoiding unnecessary morbidity. However, the actual
long-term quality of life of patients having undergone
surgery for inverted papillomas has never been studied.
Our primary aim is to assess the long-term sequelae and the
quality of life of patients after endoscopic surgery of
sinonasal inverted papillomas. The secondary aim is to
establish which nasal symptoms, if any, are the most
prevalent before and after surgery. We used the SNOT-22
questionnaire to assess the quality of life of patients who
had undergone endoscopic surgery for sinonasal inverted
papillomas between 2000 and 2011. Twenty-seven out of
34 patients returned the questionnaire (79 % response rate).
Median follow-up was 6 years (range 1–10). Mean age was
58.9 years (range 40–85). Median SNOT-22 score was 12,
while the most frequent postoperative symptom was the
need to blow the nose (18 patients) and the most frequent
preoperative symptom was nasal obstruction. Patients after
endoscopic removal of sinonasal inverted papillomas
return to an almost normal quality of life, as measured by
the disease-specific questionnaire SNOT-22. The most
frequent symptom was the need to blow the nose.
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Introduction
Inverted papillomas are benign tumours of the sinonasal
cavity. They can cause local non-specific symptoms such
as nasal obstruction, sneezing and rhinorrhoea, and
potentially undergo malignant transformation [1]. For their
removal an external approach was used in the past; how-
ever, endoscopic sinus surgery has been the gold standard
for the last decades [2]. Currently, it is universally accepted
that the vast majority of sinonasal benign lesions can be
adequately managed by an endoscopic approach [3].
However, traditional external approaches still have a role
and are occasionally used in combination with endoscopic
surgery.
The operative morbidity of endoscopic surgery includes
bleeding, orbital complications, cerebrospinal fluid leak
and stenosis of the lacrimal pathway, with the complication
rate ranging from 0 to 20 % [4, 5].
Most studies support the conclusion that endoscopic
removal of inverted papilloma is associated with lower
recurrence rates than the external approach [2, 3, 6].
However, unlike the extended approaches for skull base
tumours, whose quality of life has been extensively studied
[7, 8], we did not find any published studies regarding the
quality of life of patients undergoing endoscopic surgery
for the removal of sinonasal inverted papillomas.
Aim of this study
Our primary aim is to assess the quality of life of patients
after surgery of sinonasal inverted papillomas. We
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hypothesise that the radical removal of these tumours will
result in a reduced quality of life for those patients com-
pared to the healthy population. We expected the average
score on the SNOT-22 questionnaire to be higher than 9.3
(the mean SNOT-22 score in the general population) [9].
Patients and methods
Participants
In this single-centre outcome study, patients between 18
and 90 years of age were included who had undergone
surgery for sinonasal inverted papillomas from 2000 until
2011, in the Academic Medical Center (AMC) in Ams-
terdam, the Netherlands.
Methods
To score the quality of life, the disease-specific question-
naire SNOT-22 was used and patients were told that par-
ticipation was voluntary and that not returning the
questionnaire would not affect the care they would receive.
Statistical analysis
All statistical analyses were performed using IBM SPSS
22.0 statistical software (IBM Corp. Released 2013.
IBM SPSS Statistics for Windows, Version 22.0.
Armonk, NY: IBM Corp.c., Chicago, IL, USA).
Descriptive statistics were calculated and reported for
all measures. The Kolmogorov–Smirnov test and Sha-
piro–Wilk test were used to assess the distribution of
the data. Median and range were used for the descrip-
tion of non-parametric data, while differences between
groups were calculated with the Mann–Whitney U Test
as appropriate.
Results
Between the years 2000 and 2011, 37 patients were man-
aged with sinonasal inverted papillomas. After excluding
the patients who were treated by the external approach (2
patients) and the patients who were no longer alive (1
patient), there were 34 patients eligible for inclusion.
Of these, 27 patients returned the completed question-
naire (Fig. 1), resulting in a response rate of
27/34 = 79 %. Patients included 8 women and 19 men,
with a mean age of 58.9 years (SD 9.8), and an age range
of 40–85 years. Fifteen patients were under 60 years, 12
patients were 60 years or older. None of the patients had
undergone radiation therapy in the past.
The median follow-up was 6 years, with a range of
1–10 years (Table 1).
The Kolmogorov–Smirnov test and Shapiro–Wilk test
showed that distribution of the data was not normal (Kol-
mogorov–Smirnov: p = 0.000, Shapiro–Wilk: p = 0.000).
Therefore, the Mann–Whitney U test was used for com-
paring groups, and medians were given instead of means
for the SNOT-22 scores.
When comparing the medians of below and over
60 years of age, the median SNOT-22 score for the patients
under 60 was 11.5, and for the patients of 60 and above it
was 12 (Table 2). This was not significant (p = 0.456).
The total median SNOT-22 score for all patients was 12.
The vast majority of patients had little or no nasal
complaints. Scoring the SNOT 22, the most frequently
reported symptom was the need to blow the nose; as
reported by 18 out of 27 patients (median 1, range 0–5).
Other symptoms reported were waking up at night (15
patients), postnasal and thick nasal drip (each 14 patients)
and sneezing (13 patients). A median score per symptom is
written in Table 3.
Preoperative symptoms which led to consulting the Ear-,
Nose-, Throat specialist were known in all patients. 19
patients (70 %) complained of nasal obstruction, 9 of rhi-
norrhoea and in three patients the inverted papilloma was
found coincidentally when examining polyposis nasi. Other
reported symptoms were, e.g., headache and a pressure
feeling in head and/or face (Table 4). Twelve patients had
multiple symptoms. There was no relationship between the
type or number of preoperative symptoms and the post-
operative SNOT-22 score.
The extent of the surgery was known in all 27 patients
(Table 5). Six underwent a wide local excision of the
inverted papilloma, 16 underwent an ethmoidectomy and 5
underwent a medial maxillectomy. The nasolacrimal duct
was cut in 2 patients; both underwent a medial maxillec-
tomy and had a SNOT-22 score of 25. There was no sig-
nificant difference in SNOT-22 scores between patients
having undergone a wide local excision (median SNOT-22
score 18, range 5–38) and patients having undergone a
medial maxillectomy (median SNOT-22 score 23, range
7–25, p = 0.792). SNOT-22 scores were lower in patients
having undergone an ethmoidectomy (median SNOT-22
score 10.5, range 0–61), but the difference was not statis-
tically significant (p = 0.203).
Discussion
Findings and analysis of the results
Our most important findings were that patients who had
undergone surgery of benign sinonasal tumours appear to
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have a very mildly impaired quality of life (median of 12
on the SNOT-22 score). Healthy people score an average of
9.3 points on the SNOT-22 [9], while patients with chronic
rhinosinusitis have an average of 51.8 [10]. The difference
of 3 points is measurable but of doubtful clinical signifi-
cance; it has been shown that a change of less than 9 points
cannot be perceived as a real improvement or impairment
by the patient [11].
A study that used SNOT-20 to assess the quality of life
of patients after endoscopic removal of tumours was pub-
lished by Harrow and co-authors [12]. Although the post-
operative mean SNOT-20 score for benign tumours was
11.6 in their study, grossly equivalent to 13 in our scale,
comparisons are difficult, as their study includes skull base
tumours with significantly less follow-up and other kinds of
benign sinonasal tumours which were not included in our
study. In a way, our study is complementary to the study by
Harrow, as it shows that quality of life continues to
improve with time—our better reported quality of life may
reflect the fact that their follow-up was 6 months, while
ours was several years.
SNOT-22 questionnaires are also used for other sino-
nasal surgery. In all studies found, the SNOT-22 scores are
higher than 9, which means there is an impaired quality of
life after the operation; this confirms our findings. Buck-
land and co-authors report that the average postoperative
SNOT-22 score in patients having undergone successful
septal surgery is 19.3 after approximately 3 months [13].
Assessed for eligibility 
N=37 
Excluded N=3 
External approach N=2 




Could not be contacted           N=7 
Included
N=27 
Fig. 1 Flow-chart included
patients
Table 1 Follow-up and SNOT-22 score
Years of
follow-up
Number of patients Median SNOT-22
score (range)
1–5 12 11.5 (0–61)
6–10 15 12 (0–61)
p value: 0.683
Table 2 Age and SNOT-22 score
Age Number of patients Median SNOT-22 score (range)
\60 15 13 (2–61)
C60 12 11.5 (0–38)
p value: 0.456
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Ransom and co-authors report an average SNOT-22 score
of 14 a year after complete endoscopic resection of anterior
skull base neoplasms [14]. The preoperative mean SNOT-
22 score in their patient group was 47.
In our patient group, there is after 5 years a very minor,
barely measurable and likely not of any clinical signifi-
cance, quality of life impairment in patients who undergo
an endoscopic excision of benign tumours.
The most frequent symptom reported in our patient
group was the need to blow the nose, although the median
score was reported as 1. This is likely reflective of a larger
sinonasal cavity. Other frequent symptoms were waking up
at night, postnasal discharge, thick nasal discharge and
sneezing.
The most frequently reported preoperative symptoms
were nasal obstruction and rhinorrhoea.
In studies about inverted papilloma and chronic rhi-
nosinusitis, the most frequent symptom was nasal
obstruction, which was confirmed in our study [4, 15, 16].
No postoperative patient group comparable to ours has
been studied using the SNOT-22.
After analysis, it appeared we did not have to correct the
results for the outliers. There are two patients scoring more
than 60 on the SNOT-22 score, the result of unrelated co-
morbidity (malignancy and depression). When these
patients are removed from the database, the median
becomes 11, suggesting that the results are not majorly
influenced by those outliers.
Furthermore, the results did not have to be corrected for
the extent of the endoscopic surgery, since there was no
significant difference between the SNOT-22 scores in the
different groups.
Strengths and limitations
The strengths of our study include that the patients were
approached personally and at different times of the day, to
avoid just reaching the patients who were not working or
not able to work. The long follow-up of the patients was a
Table 3 Median scores per symptom and number of patients reporting the symptom
Symptom Median (range) Number of patients Symptom Median (range) Number of patients
Need to blow the nose 1 (0–5) 18 Reduced sense of taste/smell 0 (0–5) 10
Waking up at night 1 (0–5) 15 Lack of good night sleep 0 (0–5) 9
Postnasal discharge 1 (0–4) 14 Cough 0 (0–3) 8
Thick nasal discharge 1 (0-5) 14 Dizziness 0 (0–5) 7
Sneezing 0 (0–5) 13 Reduced productivity 0 (0–3) 7
Reduced concentration 0 (0–4) 12 Frustration/restlessness/irritability 0 (0–4) 7
Blockage of the nose 0 (0–4) 12 Sadness 0 (0–4) 5
Waking up tired 1 (0–5) 11 Facial pain 0 (0–5) 4
Fatigue during the day 1 (0–5) 11 Embarrassment 0 (0–4) 4
Rhinorrhea 0 (0–4) 11 Earfullness 0 (0–2) 3
Difficulty falling asleep 0 (0–3) 10 Ear pain 0 (0–1) 2
Table 4 Reported reasons for consulting the ENT-specialist
Reported reason Number of patients Reported reason Number of patients
Obstruction 19 Epistaxis 1
Rhinorrhoea 9 Felt an abnormality while picking nose 1
Headache 4 Sneezing 1
Pressure in head/face 4 Hyposmia 1
Occasionally at examination for polyposis nasi 3 Facial pain 1
Postnasal drip 2





Wide local excision 6 18 (5–38)
Ethmoidectomy 16 10.5 (0–61)
Medial maxillectomy 5 23 (7–25)
Including cut of the
nasolacrimal duct
2 25 (25–25)
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strength of the study, which is longer than current studies
have investigated. One of the limitations of our research is
that the patient group is small (27 patients) and that we
could not reach 100 % of the patients. The majority of
patients who did not respond appeared to have moved,
which meant they could not be contacted by telephone or
through mail. In a few, there may be nonresponse bias;
patients without any symptoms, or, on the contrary,
patients with major complaints and plenty of symptoms,
may not have answered; however, an analysis of the non-
responders did not show any obvious difference in age or
preoperative symptoms. Furthermore, we do not have a
preoperative SNOT-22 score to compare, as we are
restricted by the retrospective nature of our study. How-
ever, we have reported preoperative symptoms, which give
an indication for the reason of consulting the ENT-
specialist.
Conclusion
Our study shows that patients who have undergone surgery
of benign sinonasal tumours appear to have a minor and
probably not clinically significant impairment of quality of
life (median of 12), as measured by the disease-specific
questionnaire SNOT-22. This is present at a median of
6 years of follow-up. This may have implications for the
consent process of such patients, who may have to be
instructed accordingly.
The most frequent symptom was the need to blow the
nose; 18 out of 27 patients reported this. Other frequent
symptoms were waking up at night, postnasal and thick
nasal discharge, and sneezing. The least frequent symptom
was ear pain.
This was the first study assessing the quality of life of
patients undergoing endoscopic removal of sinonasal
inverted papillomas. Since only a small group of patients
could be studied, it was not possible to draw firm conclu-
sions. Further prospective and potentially multicentre
studies may shed light on the quality of life of the patients
before and after surgery.
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